news paper icon

Analyzed News

BRIEF-Biotec Pharmacon says Woulgan will be listed on UK Drug Tariff

* Says its wholly owned subsidiary Biotec BetaGlucans received feedback from NHS that Woulgan, a wound treatment product, will be listed on UK Drug Tariff from January 2018 [Source]

Publication Date:


Category: companyNews

Topics: Tariff, listed, Woulgan, January, treatment product, wound, feedback, BetaGlucans received, Biotec, subsidiary, owned, wholly, Pharmacon, BRIEF-Biotec


Related Articles